Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant
Abstract
Authors
ME Romero Prada NC Roa Cardenas EC Vasquez Melo G Acero LM Huerfano M de Los Rios de Acevedo